IL-21, a significant cytokine in the IFN signaling pathway, is notably elevated in SS patients, and SGRNA sequencing has revealed significantly higher levels of IL-21 and IL-21-inducible genes (IL-21R, JAK3, STAT1, and CXCL10) (176, 177). This evidence concerns the gene IL21 and synovial sarcoma.